‘Concerningly Low’ Use of CVD Meds for Secondary Prevention

‘Concerningly Low’ Use of CVD Meds for Secondary Prevention

TOPLINE: Among patients with ­cardiovascular disease (CVD) in 17 countries, many receive no medication for secondary…

Continue Reading
Trump Administration Review of Psych Meds Raises Concerns

Trump Administration Review of Psych Meds Raises Concerns

The Trump administration’s plans to study the “threat” posed by psychiatric medications in children have medical…

Continue Reading
Use of Secondary CVD Prevention Meds Still Meager Worldwide

Use of Secondary CVD Prevention Meds Still Meager Worldwide

An analysis of the PURE study shows some gains but “little to no improvement in most…

Continue Reading